Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic.
Stem Cell Reports
; 16(11): 2567-2576, 2021 11 09.
Article
in English
| MEDLINE | ID: covidwho-1525954
ABSTRACT
The significant morbidity and mortality of coronavirus disease 19 (COVID-19) prompted a global race to develop new therapies. These include interventions using cell- or cell-derived products, several of which are being tested in well-designed, properly controlled clinical trials. Yet, the search for cell-based COVID-19 treatments has also been fraught with hyperbolic claims; flouting of crucial regulatory, scientific, and ethical norms; and distorted communication of research findings. In this paper, we critically examine ethical issues and public communication challenges related to the development of cell-based therapeutics for COVID-19. Drawing on the lessons learned from this ongoing process, we argue against the rushed development of cell-based interventions. We conclude by outlining ways to improve the ethical conduct of cell-based clinical investigations and public communication of therapeutic claims.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Therapeutics
/
Communication
/
Stem Cell Transplantation
/
Pandemics
/
SARS-CoV-2
/
COVID-19
Type of study:
Experimental Studies
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Stem Cell Reports
Year:
2021
Document Type:
Article
Affiliation country:
J.stemcr.2021.09.005
Similar
MEDLINE
...
LILACS
LIS